• Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet

ISDB – International Society of Drug Bulletins

International Society of Drug Bulletins

  • Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet
  • Menu

A step backwards on pharmaceutical policy at the EU Commission: the move to directorate general (DG) Enterprise and Industry is unacceptable

September 16, 2014 Campaigns

Joint open letter to President Juncker by 28 organisations. Promoting profit over public health puts European citizens at risk. No, medicinal products are not just a commodity like any other.

Attachment: 20140916openletterpharmapolicy.pdf

Recent Publications

  • ISDB Newsletter December 2021
  • ISDB Newsletter August 2021
  • ISDB Newsletter May 2021
  • ISDB Newsletter June 2020
  • Medicamentos y riesgo de neumonía [ES]

Newsletter

Recent Campaigns

  • Letter to Charles Michel on transparency in EU institutions
  • A letter to the Prime Minister of India
  • ISDB General Assembly Paris 2019
  • News from working groups: Clinical Study Reports?
  • News from working groups: Clinical Trials Group

Contact

President
Dick Bijl
president @ isdbweb.org

Webmaster
Uw Computerstudent
toon.van.dort @ uwcomputerstudent.nl

Sign up to receive our newsletter.

Press releases

  • Statement: COVID-19 [EN]
  • ISDB General Assembly Paris 2019
  • Cochrane’s sinking ship and conflicts of interest
  • No to EMA’s provision of confidential scientific advice to drug companies (November 2017)
  • Supplementary protection certificates (SPCs) delay access to affordable medicines (September 2017)

Newsletters

  • ISDB Newsletter December 2021
  • ISDB Newsletter August 2021
  • ISDB Newsletter May 2021
  • ISDB Newsletter June 2020
  • Newsletter ISDB 2019 vol. 32 nr. 1, March 2019

© 2022 ISDB – International Society of Drug Bulletins.